Your browser doesn't support javascript.
Severe Asthma, Telemedicine, and Self-Administered Therapy: Listening First to the Patient.
Guarnieri, Gabriella; Caminati, Marco; Achille, Alessia; Vaia, Rachele; Chieco Bianchi, Fulvia; Senna, Gianenrico; Vianello, Andrea.
  • Guarnieri G; Respiratory Pathophysiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35126 Padova, Italy.
  • Caminati M; Department of Medicine, University of Verona, Verona University Hospital, P.le L. Scuro 10, 37134 Verona, Italy.
  • Achille A; Respiratory Pathophysiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35126 Padova, Italy.
  • Vaia R; Allergy Unit, Asthma Center, Verona University Hospital, P.le L. Scuro 10, 37134 Verona, Italy.
  • Chieco Bianchi F; Respiratory Pathophysiology Unit, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Via Giustiniani 2, 35126 Padova, Italy.
  • Senna G; Department of Medicine, University of Verona, Verona University Hospital, P.le L. Scuro 10, 37134 Verona, Italy.
  • Vianello A; Allergy Unit, Asthma Center, Verona University Hospital, P.le L. Scuro 10, 37134 Verona, Italy.
J Clin Med ; 11(4)2022 Feb 12.
Article in English | MEDLINE | ID: covidwho-1686844
ABSTRACT
Severe asthma patients are at an increased risk of major complications and they need to be monitored regularly. The COVID-19 pandemic has notably impacted on the health care resources. The telemedicine approach applied to the follow-up of asthmatic patients has been proven to be effective in monitoring their disease and their adherence to the therapy. The aim of our study was to investigate the satisfaction of severe asthma patients before the activation of a telemedicine management, as well as their current experience with self-administration of injection therapy. An ad hoc questionnaire was developed and sent by e-mail to 180 severe asthma patients. Most of subjects, 82%, were confident with the idea of doing self-measurements and self-managing their disease. Further, 77% of subjects favoured to carry out virtual visits and telemedicine. Regarding the home treatment, 93% of patients considered the self-injection therapy easy, 94% of subjects felt safe, and 93% were not worried while self-administering. Only mild adverse events were reported in 22% of patients after self-administration. Our results showed an agreement between what is considered necessary and practicable by healthcare personnel and what is perceived by the severe asthma patients in terms of treatment and monitoring of the disease with Telehealth. Biologics have a safety profile and can be easily self-administred at home.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Jcm11040960

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Year: 2022 Document Type: Article Affiliation country: Jcm11040960